SCHEMBL10201488

SCHEMBL10201488

C#Cc1ccc2c(ccc3nc([C@@H]4CCCN4C(=O)OC(C)(C)C)[nH]c32)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 2/20 0.40
PTGES O14684 2/20 0.39
HCRTR1 O43613 6/20 0.38
HCRTR2 O43614 6/20 0.38
GABRG2 P18507 3/20 0.38
GABRB3 P28472 3/20 0.38
GABRA5 P31644 3/20 0.38
GABRA6 Q16445 3/20 0.38
GABRA4 P48169 2/20 0.38
CHEK2 O96017 1/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
NPC1 O15118 1/20 0.37
RAB9A P51151 1/20 0.37
GABRA1 P14867 2/20 0.36
GABRA2 P47869 2/20 0.36
TSHR P16473 2/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 1/20 0.36
GABRA3 P34903 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10201174 0.89 HCRTR1 (0.43) HCRTR1HCRTR2CHEK2
SCHEMBL19488784 0.89 UCHL1 (0.41) L3MBTL1PTGESHCRTR1HCRTR2GABRG2
SCHEMBL6125919 0.86 HCRTR1 (0.44) L3MBTL1PTGESHCRTR1HCRTR2CHEK2
SCHEMBL6125920 0.86 HCRTR1 (0.44) L3MBTL1PTGESHCRTR1HCRTR2CHEK2
SCHEMBL203894 0.86 HCRTR1 (0.47) L3MBTL1PTGESHCRTR1HCRTR2CHEK2
SCHEMBL2706317 0.86 HCRTR1 (0.47) L3MBTL1PTGESHCRTR1HCRTR2CHEK2
SCHEMBL10201148 0.86 GABRG2 (0.35) L3MBTL1GABRG2GABRB3GABRA5GABRA6
SCHEMBL12373604 0.85 GABRG2 (0.35) GABRG2GABRB3GABRA5GABRA6GABRA4
SCHEMBL571669 0.84 PTGES (0.44) L3MBTL1PTGESHCRTR1HCRTR2GABRG2
SCHEMBL571668 0.84 PTGES (0.44) L3MBTL1PTGESHCRTR1HCRTR2GABRG2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2601188-B1 HEPATITIS C VIRUS INHIBITORS BRISTOL MYERS SQUIBB CO (US) 2017-10-18 EP disclosed
WO-2012018325-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-02-09 WO disclosed